Primecap Management Co. CA reduced its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 23.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,756,962 shares of the medical research company

Canada Pension Plan Investment Board boosted its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 39.7% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 963,209 shares of the medical research company

Jones Financial Companies Lllp trimmed its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 8.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 141,894 shares of the medical resea

Evolve Private Wealth LLC reduced its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 63.9% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,980 shares of the medical research company

Aberdeen Wealth Management LLC trimmed its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 64.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,542 shares of the medical research company

Amgen, Thermo Fisher and PepsiCo headline Zacks??? latest research, with growth drivers, raised outlooks and key risks in focus.

L2 Asset Management LLC boosted its holdings in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 12.6% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 31,241 shares of the medical research company

Legal & General Group Plc trimmed its position in Amgen Inc. (NASDAQ:AMGN - Free Report) by 1.4% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,816,942 shares of the medical research company

The Manufacturers Life Insurance Company lowered its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 8.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,150,794 shares of the medical resear

Trajan Wealth LLC increased its position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 38.5% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 24,096 shares of the medical research company

WASHINGTON, D.C. — The Federal Trade Commission is urging a federal appeals court to reject Amgen Inc.’s argument that its acquisition of patent rights protecting the arthritis drug Enbrel is …

The Federal Trade Commission is urging a federal appeals court to preserve antitrust scrutiny of Amgen Inc.’s acquisition of patent rights connected to

Amgen stock is trading close to a fresh 52-week high while management’s FY 2026 EPS guidance of 22.3

OMERS ADMINISTRATION Corp lowered its position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 8.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 37,717 shares of the medical research company